Stay updated on Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page’s displayed revision/version marker was incremented from v3.5.2 to v3.5.3, reflecting a site release/update rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-25T18:53:49.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:44:24.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Footer and policy updates were added, including release notes, privacy and accessibility information, and government links.
    Difference
    100%
    Check dated 2026-03-28T03:46:30.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Footer/navigation items and several archived study documents were removed. The essential trial data remains accessible on the page.
    Difference
    22%
    Check dated 2026-03-21T01:17:26.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No substantive content changes are visible.
    Difference
    0.1%
    Check dated 2026-03-06T17:49:35.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No changes to the study details, eligibility criteria, or outcomes were observed.
    Difference
    0.1%
    Check dated 2026-02-13T12:30:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.